Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,588 GBX | -0.16% | -2.55% | +9.47% |
Apr. 17 | GSK Reports Positive Data for Gonorrhea Treatment Gepotidacin, Shingles Vaccine Shingrix | MT |
Apr. 17 | GSK: positive clinical results for gonorrhea | CF |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.47% | 80.88B | |
+28.79% | 676B | |
+23.48% | 554B | |
-7.64% | 349B | |
+15.00% | 318B | |
+5.99% | 291B | |
+2.94% | 210B | |
-0.37% | 204B | |
-9.82% | 194B | |
-11.71% | 144B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- Transcript : GlaxoSmithKline plc, Q4 2021 Earnings Call, Feb 09, 2022